Form EFFECT Elicio Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 20, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elicio phase 2 pancreatic cancer trial misses primary endpoint
- MicroVision Begins Commercial Production of MOVIA Pro Enabling Physical AI at the Edge.
- Best Crypto Presale 2026: Tesla-SpaceX Merger Talks Meet Remittix’s $33M Raise and November 24 Launch
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share